Industry Bulletins | July 24, 2019
CVS Health Announces Start Of Clinical Trial For New Home Hemodialysis Device
CVS Health announced the initiation of a clinical trial designed to evaluate the safety and efficacy of the HemoCare Hemodialysis System for administration of home hemodialysis. The innovative device includes safety features and is designed to make home hemodialysis simple for health care consumers. Home hemodialysis helps facilitate longer, more frequent dialysis treatments as compared to in-center treatments, and published clinical research has found that longer, more frequent hemodialysis treatments result in better health outcomes in appropriate populations. The clinical trial of up to 70 individuals will be conducted at up to ten sites in the United States.
Currently . . .